Pharmaceuticals

Royalty Pharma, a PM Capital holding, is reshaping how breakthrough medicines are funded and developed. By Alex Warnaar, PM Capital

The recent “Most Favoured Nation” executive order is creating an overhang on biotech stocks and opportunities for selective stock-pickers.

India has emerged as the pharmacy to the world - a point illustrated during the pandemic and driven by scale economics and export prowess.

There's robust potential in US tech, pharma and Qantas, while red flags exist in a number of ASX companies that make them short candidates.

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

The Pharma & Biotech market had a relatively positive month with 41.5% of the coverage universe posting positive share price movements for the month of September. Over...

In this wire, we take a look at five ASX-listed pharma & biotech companies whose share prices rallied in July.

In this episode, Nina shares her background and what it taught her about the challenge of running a biotech firm.

The growth of this specialised biopharmaceutical field has coincided with increased attention from the large global pharma companies

There were three companies in the Pharma & Biotech sector whose share prices rallied 70%+ in June, although share price increases for the sector were relatively muted...